Selective JAK Inhibition in RA vs PV - Quiz - MDSpire

Selective JAK Inhibition in RA vs PV

Tofacitinib induced remission of rheumatoid arthritis but spared JAK2-driven polycythemia vera in a single case report.

  • By

  • Julia Cipriano

  • February 13, 2026

  • 3 min

Share

Original Source(s)

Selective JAK Inhibition in RA vs PV

  • by Julia Cipriano

  • February 13, 2026

Related Content

Evaluating the Quality and Trustworthiness of Short Videos on Rheumatoid Arthritis Found on Bilibili and TikTok: A Cross-Sectional Analysis

Upadacitinib and Pain in RA, PsA

Mediation analysis suggests direct and indirect effects on pain reduction in rheumatoid and psoriatic arthritis.

Comorbidities Worsen Carpal Tunnel Outcomes

Patients with systemic diseases had worse symptoms and function before and following surgery, though improvement after release was similar.